📰 Jamese Ip News
Jamese Ip News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jamese Ip. Real-time updates on events, politics, business and more.
November 15, 2023
A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.
October 6, 2023
Six in 10 patients had heart rate restored to normal within 30 minutes
October 3, 2023
Investigational etripamil nasal spray is well tolerated for self-treating recurrent episodes of PSVT without medical supervision.
September 28, 2023
A fast-acting medication delivered as a nasal spray may someday allow patients with intermittent rapid heartbeats to treat it themselves as soon as they develop symptoms, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
September 28, 2023
The safety and tolerability of etripamil, an investigational nasal spray for paroxysmal supraventricular tachycardia (PSVT), are maintained in new data from the NODE-302 extension study.
September 27, 2023
Long-term data from NODE-302 suggests self-administered etripamil nasal spray for rapid heartbeat during PSVT well-tolerated and effective.
September 27, 2023
Results from the open-label extension study show a consistent response among patients with recurrent PSVT episodes.